Newsroom

Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs

Publish Date:

Thursday, December 20, 2018

Category:

News Organization:

Kaiser Health News

Source URL:

Multimedia Files:

Preview image